|
|
|
|
Significant Efficacy and Long-term Safety Difference With TAF-Based STR in Naïve Adults
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
Jose Arribas,1 Melanie Thompson,2 Paul Sax,3 Bernhard Haas,4 Cheryl McDonald,5 David Wohl,6 Edwin DeJesus,7 Amanda Clarke,8 Moupali Das,9 Scott McCallister9
1Hospital Universitario La Paz, Madrid, Spain; 2AIDS Research Consortium of Atlanta, GA; 3Brigham and Women’s Hospital, Boston, MA; 4LKH Graz Süd-West, Graz, Austria; 5Tarrant County Infectious Disease Associates, Fort Worth, TX;
6University of North Carolina at Chapel Hill School of Medicine; 7Orlando Immunology Center, Orlando, FL; 8Brighton & Sussex University Hospitals NHS Trust, Brighton, UK; 9Gilead Sciences, Inc., Foster City, CA
|
|
|
|
|
|
|